These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3014357)

  • 21. [Intermittent self-catheterization in multiple sclerosis].
    Luoto E; Jussilainen M; Sandell S
    Sairaanhoitaja (1991); 1993; (1):17-20. PubMed ID: 8427949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family caregiver quality of life in multiple sclerosis among Kuwaitis: a controlled study.
    Alshubaili AF; Ohaeri JU; Awadalla AW; Mabrouk AA
    BMC Health Serv Res; 2008 Oct; 8():206. PubMed ID: 18840287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of quality of life in patients with multiple sclerosis].
    Titlić M; Matijaca M; Marović A; Lusić I; Tonkić A; Jukić I; Karacić S; Capkun V
    Acta Med Croatica; 2007 Sep; 61(4):355-60. PubMed ID: 18044468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z; Rebeś Z; Kubasiewicz B
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatigue in relation to perceived health: people with multiple sclerosis compared with people in the general population.
    Flensner G; Ek AC; Landtblom AM; Söderhamn O
    Scand J Caring Sci; 2008 Sep; 22(3):391-400. PubMed ID: 18840223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-rated physical health predicts change in disability in multiple sclerosis.
    Drulovic J; Riise T; Nortvedt M; Pekmezovic T; Manigoda M
    Mult Scler; 2008 Aug; 14(7):999-1002. PubMed ID: 18505776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimensions underlying outcome criteria in bipolar I disorder.
    Brieger P; Röttig S; Röttig D; Marneros A; Priebe S
    J Affect Disord; 2007 Apr; 99(1-3):1-7. PubMed ID: 16996137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of multiple sclerosis].
    Harrer G
    Wien Med Wochenschr; 1985 Jan; 135(1-2):42-5. PubMed ID: 2983502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Training examiners to administer a quantitative neurological examination for a multicenter clinical trial.
    Henderson WG; Tourtellotte WW; Potvin AR
    Arch Phys Med Rehabil; 1975 Jul; 56(7):289-95. PubMed ID: 167673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Catamnestic studies of the results of rehabilitation of patients with multiple sclerosis].
    Magierowski S; Cendrowski W
    Neurol Neurochir Pol; 1971; 5(1):103-8. PubMed ID: 4322876
    [No Abstract]   [Full Text] [Related]  

  • 31. [The status of oncologic patients in radiotherapy--physical and psychological aspects].
    Frischenschlager O; Hohenberg G; Handl-Zeller L
    Wien Klin Wochenschr; 1991; 103(2):40-4. PubMed ID: 2024526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disability, disease duration, and rehabilitation service needs in multiple sclerosis: patient perspectives.
    Kraft GH; Freal JE; Coryell JK
    Arch Phys Med Rehabil; 1986 Mar; 67(3):164-8. PubMed ID: 3954578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient attitude as a function of disease state in multiple sclerosis.
    Evers KJ; Karnilowicz W
    Soc Sci Med; 1996 Oct; 43(8):1245-51. PubMed ID: 8903129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disseminated sclerosis].
    Demina TL; Boĭko AN
    Med Sestra; 1990 Feb; 49(2):21-4. PubMed ID: 2329932
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple sclerosis: it epidemiological, genetic, and health care impact.
    Williams R; Rigby AS; Airey M; Robinson M; Ford H
    J Epidemiol Community Health; 1995 Dec; 49(6):563-9. PubMed ID: 8596089
    [No Abstract]   [Full Text] [Related]  

  • 36. [Change in subjective well being and physical complaints in multiple sclerosis patients within the scope of inpatient therapy lasting several weeks].
    Aschoff JC; Braitinger S
    Nervenarzt; 1986 May; 57(5):287-92. PubMed ID: 3014357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lived experience of relapsing multiple sclerosis: a phenomenological study.
    Miller CM
    J Neurosci Nurs; 1997 Oct; 29(5):294-304. PubMed ID: 9361999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial.
    McAuley E; Motl RW; Morris KS; Hu L; Doerksen SE; Elavsky S; Konopack JF
    Mult Scler; 2007 Jun; 13(5):652-9. PubMed ID: 17548446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Arch Neurol; 2004 May; 61(5):679-86. PubMed ID: 15148144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in subjective health in sports participating and sedentary patients after 4-week treatment in a rehabilitation clinic].
    Yaldai S; Trowitzsch L
    Rehabilitation (Stuttg); 1995 Feb; 34(1):35-42. PubMed ID: 7716338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.